PLZF regulates CCR6 and Is critical for the acquisition and maintenance of the Th17 phenotype in human cells

Journal of Immunology

Volumn 194, Issue 9, 2015, Pages 4350-4361

  Singh, Satya P ^a   Zhang, Hongwei H ^a   Tsang, Hsinyi ^a   Gardina, Paul J ^a   Myers, Timothy G ^a   Nagarajan, Vijayaraj ^a   Lee, Chang Hoon ^a   Farber, Joshua M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; E1A ASSOCIATED P300 PROTEIN; HISTONE; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; PROTEIN BINDING; ZBTB16 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RORC GENE; TH17 CELL; TRANSCRIPTION INITIATION SITE; UMBILICAL CORD BLOOD; UPREGULATION; ZBTB16 GENE; ANIMAL; CYTOLOGY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOLOGIC MEMORY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHENOTYPE; PROTEIN BINDING; RECEPTORS, CCR6; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84928472950     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401093     Document Type: Article

References (66)

1. Weaver, C. T., C. O. Elson, L. A. Fouser, and J. K. Kolls. 2013. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8: 477-512.
2. Sie, C., T. Korn, and M. Mitsdoerffer. 2014. Th17 cells in central nervous system autoimmunity. Exp. Neurol. 262(Pt. A): 18-27.
3. Hirahara, K., K. Ghoreschi, A. Laurence, X. P. Yang, Y. Kanno, and J. J. O'Shea. 2010. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev. 21: 425-434.
4. Kurebayashi, Y., S. Nagai, A. Ikejiri, and S. Koyasu. 2013. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells 18: 247-265.
5. Miossec, P., and J. K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11: 763-776.
6. Huh, J. R., and D. R. Littman. 2012. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur. J. Immunol. 42: 2232-2237.
7. Xiao, S., N. Yosef, J. Yang, Y. Wang, L. Zhou, C. Zhu, C. Wu, E. Baloglu, D. Schmidt, R. Ramesh, et al. 2014. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity 40: 477-489.
8. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
9. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
10. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
11. Singh, S. P., H. H. Zhang, J. F. Foley, M. N. Hedrick, and J. M. Farber. 2008. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180: 214-221.
12. Lim, H. W., J. Lee, P. Hillsamer, and C. H. Kim. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180: 122-129.
13. Schutyser, E., S. Struyf, and J. Van Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426.
14. Bachelerie, F., A. Ben-Baruch, A. M. Burkhardt, C. Combadiere, J. M. Farber, G. J. Graham, R. Horuk, A. H. Sparre-Ulrich, M. Locati, A. D. Luster, et al. 2014. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66: 1-79.
15. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204: 2803-2812.
16. Liston, A., R. E. Kohler, S. Townley, S. Haylock-Jacobs, I. Comerford, A. C. Caon, J. Webster, J. M. Harrison, J. Swann, I. Clark-Lewis, et al. 2009. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J. Immunol. 182: 3121-3130.
17. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
18. Hedrick, M. N., A. S. Lonsdorf, A. K. Shirakawa, C. C. Richard Lee, F. Liao, S. P. Singh, H. H. Zhang, A. Grinberg, P. E. Love, S. T. Hwang, and J. M. Farber. 2009. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119: 2317-2329.
19. Varona, R., V. Cadenas, L. Gómez, C. Martínez-A, and G. Márquez. 2005. CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. Blood 106: 18-26.
20. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649.
21. Steinfelder, S., S. Floess, D. Engelbert, B. Haeringer, U. Baron, L. Rivino, B. Steckel, A. Gruetzkau, S. Olek, J. Geginat, et al. 2011. Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. Blood 117: 2839-2846.
22. Duhen, T., R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10: 857-863.
23. Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent. 1993. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12: 1161-1167.
24. Suliman, B. A., D. Xu, and B. R. Williams. 2012. The promyelocytic leukemia zinc finger protein: two decades of molecular oncology. Front Oncol 2: 74.
25. Ono, R., M. Masuya, H. Nakajima, Y. Enomoto, E. Miyata, A. Nakamura, S. Ishii, K. Suzuki, F. Shibata-Minoshima, N. Katayama, et al. 2013. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells. Blood 122: 1271-1283.
26. Boukarabila, H., A. J. Saurin, E. Batsché, N. Mossadegh, M. van Lohuizen, A. P. Otte, J. Pradel, C. Muchardt, M. Sieweke, and E. Duprez. 2009. The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation. Genes Dev. 23: 1195-1206.
27. Doulatov, S., F. Notta, K. L. Rice, L. Howell, A. Zelent, J. D. Licht, and J. E. Dick. 2009. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 23: 2076-2087.
28. Constantinides, M. G., B. D. McDonald, P. A. Verhoef, and A. Bendelac. 2014. A committed precursor to innate lymphoid cells. Nature 508: 397-401.
29. Kovalovsky, D., O. U. Uche, S. Eladad, R. M. Hobbs, W. Yi, E. Alonzo, K. Chua, M. Eidson, H. J. Kim, J. S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
30. Kreslavsky, T., A. K. Savage, R. Hobbs, F. Gounari, R. Bronson, P. Pereira, P. P. Pandolfi, A. Bendelac, and H. von Boehmer. 2009. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 106: 12453-12458.
31. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
32. Wei, G., B. J. Abraham, R. Yagi, R. Jothi, K. Cui, S. Sharma, L. Narlikar, D. L. Northrup, Q. Tang, W. E. Paul, et al. 2011. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35: 299-311.
33. Eidson, M., J. Wahlstrom, A. M. Beaulieu, B. Zaidi, S. E. Carsons, P. K. Crow, J. Yuan, J. D. Wolchok, B. Horsthemke, D. Wieczorek, and D. B. Sant'Angelo. 2011. Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS One 6(9): e24441. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167854/.
34. Heintzman, N. D., R. K. Stuart, G. Hon, Y. Fu, C. W. Ching, R. D. Hawkins, L. O. Barrera, S. Van Calcar, C. Qu, K. A. Ching, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39: 311-318.
35. Creyghton, M. P., A. W. Cheng, G. G. Welstead, T. Kooistra, B. W. Carey, E. J. Steine, J. Hanna, M. A. Lodato, G. M. Frampton, P. A. Sharp, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107: 21931-21936.
36. Visel, A., M. J. Blow, Z. Li, T. Zhang, J. A. Akiyama, A. Holt, I. Plajzer-Frick, M. Shoukry, C. Wright, F. Chen, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
37. Liu, S. M., and C. King. 2013. IL-21-producing Th cells in immunity and autoimmunity. J. Immunol. 191: 3501-3506.
38. Mathew, R., M. P. Seiler, S. T. Scanlon, A. P. Mao, M. G. Constantinides, C. Bertozzi-Villa, J. D. Singer, and A. Bendelac. 2012. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 491: 618-621.
39. Buaas, F. W., A. L. Kirsh, M. Sharma, D. J. McLean, J. L. Morris, M. D. Griswold, D. G. de Rooij, and R. E. Braun. 2004. Plzf is required in adult male germ cells for stem cell self-renewal. Nat. Genet. 36: 647-652.
40. Cosmi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205: 1903-1916.
41. Chu, X., C. M. Pan, S. X. Zhao, J. Liang, G. Q. Gao, X. M. Zhang, G. Y. Yuan, C. G. Li, L. Q. Xue, M. Shen, et al China Consortium for Genetics of Autoimmune Thyroid Disease. 2011. A genome-wide association study identifies two new risk loci for Graves' disease. Nat. Genet. 43: 897-901.
42. Kochi, Y., Y. Okada, A. Suzuki, K. Ikari, C. Terao, A. Takahashi, K. Yamazaki, N. Hosono, K. Myouzen, T. Tsunoda, et al. 2010. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 42: 515-519.
43. Quan, C., Y. Q. Ren, L. H. Xiang, L. D. Sun, A. E. Xu, X. H. Gao, H. D. Chen, X. M. Pu, R. N. Wu, C. Z. Liang, et al. 2010. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat. Genet. 42: 614-618.
44. Stahl, E. A., S. Raychaudhuri, E. F. Remmers, G. Xie, S. Eyre, B. P. Thomson, Y. Li, F. A. Kurreeman, A. Zhernakova, A. Hinks, et al BIRAC Consortium; YEAR Consortium. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42: 508-514.
45. Wang, K., H. Zhang, S. Kugathasan, V. Annese, J. P. Bradfield, R. K. Russell, P. M. Sleiman, M. Imielinski, J. Glessner, C. Hou, et al. 2009. Diverse genomewide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 84: 399-405.
46. Trifari, S., C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10: 864-871.
47. Barna, M., N. Hawe, L. Niswander, and P. P. Pandolfi. 2000. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25: 166-172.
48. Savage, A. K., M. G. Constantinides, and A. Bendelac. 2011. Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling. J. Immunol. 186: 5801-5806.
49. Lee, Y. J., Y. K. Jeon, B. H. Kang, D. H. Chung, C. G. Park, H. Y. Shin, K. C. Jung, and S. H. Park. 2010. Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans. J. Exp. Med. 207: 237-246.
50. Barski, A., S. Cuddapah, K. Cui, T.-Y. Roh, D. E. Schones, Z. Wang, G. Wei, I. Chepelev, and K. Zhao. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
51. Heintzman, N. D., G. C. Hon, R. D. Hawkins, P. Kheradpour, A. Stark, L. F. Harp, Z. Ye, L. K. Lee, R. K. Stuart, C. W. Ching, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
52. Pekowska, A., T. Benoukraf, J. Zacarias-Cabeza, M. Belhocine, F. Koch, H. Holota, J. Imbert, J. C. Andrau, P. Ferrier, and S. Spicuglia. 2011. H3K4 trimethylation provides an epigenetic signature of active enhancers. EMBO J. 30: 4198-4210.
53. Koch, F., and J. C. Andrau. 2011. Initiating RNA polymerase II and TIPs as hallmarks of enhancer activity and tissue-specificity. Transcription 2: 263-268.
54. Chauchereau, A., M. Mathieu, J. de Saintignon, R. Ferreira, L. L. Pritchard, Z. Mishal, A. Dejean, and A. Harel-Bellan. 2004. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene 23: 8777-8784.
55. David, G., L. Alland, S. H. Hong, C. W. Wong, R. A. DePinho, and A. Dejean. 1998. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16: 2549-2556.
56. Guidez, F., L. Howell, M. Isalan, M. Cebrat, R. M. Alani, S. Ivins, I. Hormaeche, M. J. McConnell, S. Pierce, P. A. Cole, et al. 2005. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25: 5552-5566.
57. Hong, S. H., G. David, C. W. Wong, A. Dejean, and M. L. Privalsky. 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94: 9028-9033.
58. McConnell, M. J., and J. D. Licht. 2007. The PLZF gene of t (11;17)-associated APL. Curr. Top. Microbiol. Immunol. 313: 31-48.
59. Senbonmatsu, T., T. Saito, E. J. Landon, O. Watanabe, E. Price, Jr., R. L. Roberts, H. Imboden, T. G. Fitzgerald, F. A. Gaffney, and T. Inagami. 2003. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 22: 6471-6482.
60. Xu, D., M. Holko, A. J. Sadler, B. Scott, S. Higashiyama, W. Berkofsky-Fessler, M. J. McConnell, P. P. Pandolfi, J. D. Licht, and B. R. Williams. 2009. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity 30: 802-816.
61. Ciofani, M., A. Madar, C. Galan, M. Sellars, K. Mace, F. Pauli, A. Agarwal, W. Huang, C. N. Parkurst, M. Muratet, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
62. Zhu, J., and W. E. Paul. 2010. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 238: 247-262.
63. Zhang, F., G. Meng, and W. Strober. 2008. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9: 1297-1306.
64. Huh, J. R., M. W. Leung, P. Huang, D. A. Ryan, M. R. Krout, R. R. Malapaka, J. Chow, N. Manel, M. Ciofani, S. V. Kim, et al. 2011. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature 472: 486-490.
65. Walker, L. J., Y. H. Kang, M. O. Smith, H. Tharmalingham, N. Ramamurthy, V. M. Fleming, N. Sahgal, A. Leslie, Y. Oo, A. Geremia, et al. 2012. Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119: 422-433.
66. Massot, B., M. L. Michel, S. Diem, C. Ohnmacht, S. Latour, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2014. TLR-induced cytokines promote effective proinflammatory natural Th17 cell responses. J. Immunol. 192: 5635-5642.